Skip to main content
. 2015 Apr 22;10(4):e0124648. doi: 10.1371/journal.pone.0124648

Table 2. Comparison of Good and Mild responders.

Variables Good responders Mild responders p-value
Age (years) 51.6 ± 11.2 46.8 ± 8.9 n.s.
Duration of illness (years) 16.6 ± 5.7 13.5 ± 9.7 n.s.
Global Impression of change (pts) 2.7 ± 0.5 1.8 ± 0.6 < 0.0005
Duration of B12 injections (years) 8.1 ± 6.4 2.2 ± 2.3 < 0.0005
Interval days between B12 inj. 3.8 ± 1.9 5.8 ± 1.7 < 0.03
Folic acid mg/day 6.7 ± 6.6 1.9 ± 2.0 < 0.003
Use of high-concentrated B12 14/15 = 93% 13/23 = 57% < 0.03
MTHFR compound heterozygote 1/15 = 7% 8/23 = 35% n.s. (< 0.07)
Daily use of Thyroid hormone 7/15 = 47% 2/23 = 9% < 0.02
Daily use of prescribed analgesic 0/15 = 0% 16/23 = 70% < 0.0005
Fibromyalgia as part of ME 3/15 = 20% 12/23 = 52% n.s. (< 0.09)

Mean ± SD or frequency/percentage for a number of variables in Good (n = 15) or Mild responders (n = 23). P-value is calculated by Student’s t-test, or by Fischer’s exact two-tailed test in the categorical data. (n.s. = no significance)